J. Berenguer

发表

Glycosylated extracellular vesicles released by glioblastoma cells are decorated by CCL18 allowing for cellular uptake via chemokine receptor CCR8

T. Lagerweij, T. Wurdinger, P. Wesseling, 2018, Journal of extracellular vesicles.

Sensing of latent EBV infection through exosomal transfer of 5′pppRNA

T. Wurdinger, T. D. de Gruijl, S. Gibbs, 2016, Proceedings of the National Academy of Sciences.

Integrin-linked kinase (ILK) and src homology 2 domain-containing phosphatase 2 (SHP2): Novel targets in EGFR-mutation positive non-small cell lung cancer (NSCLC)

R. Rosell, A. Cardona, M. Santarpia, 2018, EBioMedicine.

Probucol increases glutathione peroxidase-1 activity and displays long-lasting protection against methylmercury toxicity in cerebellar granule cells.

F. Campos, I. Vendrell, S. Pons, 2009, Toxicological sciences : an official journal of the Society of Toxicology.

Sonic-hedgehog-mediated proliferation requires the localization of PKA to the cilium base

S. Pons, J. Berenguer, Rubén Alvarez-Rodríguez, 2010, Development.

Hsp90 inhibitors enhance the antitumoral effect of osimertinib in parental and osimertinib-resistant non-small cell lung cancer cell lines.

R. Rosell, J. Berenguer, N. Karachaliou, 2019, Translational lung cancer research.

Cancer Stem Cell Biomarkers in EGFR-Mutation-Positive Non-Small-Cell Lung Cancer.

R. Rosell, A. Cardona, A. Giménez-Capitán, 2019, Clinical lung cancer.

Osimertinib and pterostilbene in EGFR-mutation-positive non-small cell lung cancer (NSCLC)

R. Rosell, J. Berenguer, N. Karachaliou, 2019, International journal of biological sciences.

In Vivo Imaging Reveals Extracellular Vesicle-Mediated Phenocopying of Metastatic Behavior

Jacco van Rheenen, Thomas Wurdinger, Raymond Michel Schiffelers, 2015, Cell.

Common Co-activation of AXL and CDCP1 in EGFR-mutation-positive Non-Small Cell Lung Cancer Associated With Poor Prognosis

M. Okada, T. Mok, S. Ou, 2018, EBioMedicine.

STAT3 as a potential immunotherapy biomarker in oncogene-addicted non-small cell lung cancer

R. Rosell, J. Berenguer, N. Karachaliou, 2018, Therapeutic advances in medical oncology.

LCOR mediates interferon-independent tumor immunogenicity and responsiveness to immune-checkpoint blockade in triple-negative breast cancer

L. Pusztai, R. Gomis, Yibin Kang, 2022, Nature Cancer.

Introducing cloned genes into cultured neurons providing novel in vitro models for neuropathology and neurotoxicity studies.

M. Aschner, S. Pons, J. Berenguer, 2011, Neuromethods.

MicroRNA 22 Regulates Cell Cycle Length in Cerebellar Granular Neuron Precursors

F. Llorens, S. Pons, L. Sumoy, 2013, Molecular and Cellular Biology.

in Cerebellar Granular Neuron Precursors MicroRNA 22 Regulates Cell Cycle Length

F. Llorens, S. Pons, L. Sumoy, 2014 .

Bone Morphogenetic Protein 2 Opposes Shh-mediated Proliferation in Cerebellar Granule Cells through a TIEG-1-based Regulation of Nmyc*

S. Pons, J. Berenguer, M. Barzi, 2007, Journal of Biological Chemistry.

Cell memory of epithelial-mesenchymal plasticity in cancer.

T. Celià-Terrassa, J. Berenguer, 2021, Current opinion in cell biology.

Chapter 7 | Intravital Imaging Reveals Extracellular Vesicle Transfer between Tumor Cells and Its Effect on Metastasis Ev-communication between Tumor Cells in Vivo Ev-communication between Tumor Cells in Vivo Ev-communication between Tumor Cells in Vivo Concluding Remarks Ev-communication between Tu

R. Schiffelers, Elzo de Wit, J. van Rheenen, 2022 .

Anaplastic lymphoma kinase inhibitors in phase I and phase II clinical trials for non-small cell lung cancer

G. Altavilla, R. Rosell, M. Santarpia, 2017, Expert opinion on investigational drugs.

BRAF Mutations Classes I, II, and III in NSCLC Patients Included in the SLLIP Trial: The Need for a New Pre-Clinical Treatment Rationale

R. Rosell, T. Bivona, J. Berenguer, 2019, Cancers.

Rearranged EML4-ALK fusion transcripts sequester in circulating blood platelets and enable blood-based crizotinib response monitoring in non-small-cell lung cancer

T. Wurdinger, E. Smit, E. Thunnissen, 2015, Oncotarget.

Rearranged EML4-ALK fusion transcripts sequester in circulating blood platelets and enable blood-based crizotinib response monitoring in non-small-cell lung cancer

E. Smit, E. Thunnissen, R. Rosell, 2015, Oncotarget.

SRC and PIM1 as potential co-targets to overcome resistance in MET deregulated non-small cell lung cancer

M. Fassan, F. de Marinis, R. Rosell, 2020, Translational lung cancer research.

The combination of checkpoint immunotherapy and targeted therapy in cancer.

R. Rosell, J. Berenguer, N. Karachaliou, 2017, Annals of translational medicine.

The Present and Future of Liquid Biopsies in Non-Small Cell Lung Cancer: Combining Four Biosources for Diagnosis, Prognosis, Prediction, and Disease Monitoring

R. Rosell, J. Berenguer, N. Karachaliou, 2018, Current Oncology Reports.

EML4-ALK rearrangement in blood platelets and outcome to crizotinib in non-small-cell lung cancer patients.

T. Wurdinger, E. Smit, E. Thunnissen, 2015 .

Sonic-hedgehog-mediated proliferation requires the localization of PKA to the cilium base

S. Pons, J. Berenguer, Anghara Menéndez, 2010, Journal of Cell Science.

Combining plasma-based biosources to predict treatment response in NSCLC patients.

J. Berenguer, N. Karachaliou, J. Bracht, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Combining plasma-based biosources to predict treatment response in NSCLC patients.

J. Berenguer, N. Karachaliou, J. Bracht, 2018 .

PIM-1 inhibition with AZD1208 to prevent osimertinib-induced resistance in EGFR-mutation positive non-small cell lung cancer

R. Rosell, J. Berenguer, N. Karachaliou, 2019, Journal of Cancer Metastasis and Treatment.

Integrin-linked kinase (ILK) and src homology 2 domain-containing phosphatase 2 (SHP2): Novel targets in EGFR-mutation positive non-small cell lung cancer (NSCLC)

R. Rosell, A. Cardona, M. Santarpia, 2018, EBioMedicine.

Correction to: The Present and Future of Liquid Biopsies in Non-Small Cell Lung Cancer: Combining Four Biosources for Diagnosis, Prognosis, Prediction, and Disease Monitoring

R. Rosell, J. Berenguer, N. Karachaliou, 2020, Current Oncology Reports.